Linkquest, Inc.

Linkquest, Inc. specializes in extracorporeal ultrasound imaging devices. Their portfolio includes handheld transducers like convex arrays, linear arrays, phase arrays, and microconvex arrays, as well as rectal and vaginal ultrasound transducers. They also produce general-purpose ultrasound imaging systems, such as the LinkQuest Diagnostic Ultrasound System, including its model SQ860, which incorporates 3D imaging capabilities. These devices are designed for diagnostic imaging applications.

Linkquest, Inc. is headquartered in the United States. Their devices fall under FDA classification as Class II, which typically requires premarket clearance through pathways like the 510(k) process or compliance with the FDA’s Unique Device Identifier (UDI) system. These regulatory listings ensure their products meet US standards for safety and performance before entering the market.

Linkquest, Inc.’s devices are listed in the FDA’s 510(k) premarket notification database and the FDA’s Unique Device Identifier (UDI) system. These registries track authorised medical devices in the US, ensuring transparency and compliance with regulatory requirements for ultrasound imaging systems and transducers.

Linkquest, Inc.’s ultrasound devices are classified as FDA Class II. This classification is based on their intended use—diagnostic imaging—which requires a higher level of scrutiny than Class I devices but does not necessitate the stringent controls of Class III. The classification ensures that these devices undergo premarket review to confirm their safety and effectiveness before commercial distribution.